4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-029509
President and CEO bought 20,000 shares at $5.10 ($101,908)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2019-12-16 | Purchase | +20,000 | $5.10 | $101,908 | 652,216 | D: show line 1 in the form |
| Open-market purchases · 20,000 sh · avg $5.10 · $101,908 | |||||||
Loading xslF345X03/doc4.xml…